{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:57:50Z","timestamp":1792684670946,"version":"4.5.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.npep.2021.102196","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:03:00Z","timestamp":1630580580000},"page":"102196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease"],"prefix":"10.1016","volume":"90","author":[{"given":"Deepthi","family":"Rapaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veera Raghavulu","family":"Bitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Reddy","family":"Challa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Adiukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"A","key":"10.1016\/j.npep.2021.102196_bb0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.physbeh.2016.06.013","article-title":"Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor","volume":"64","author":"Abbassian","year":"2016","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.npep.2021.102196_bb0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer\u2019s disease anti-inflammatory prevention trial and its follow-up study","volume":"11","author":"ADAPT-FS Research Group","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"18","key":"10.1016\/j.npep.2021.102196_bb0015","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1182\/blood-2012-06-435362","article-title":"Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression","volume":"120","author":"Adhikary","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.npep.2021.102196_bb0020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.54.3.588","article-title":"A randomized controlled trial of prednisone in Alzheimer\u2019s disease. Alzheimer\u2019s Disease Cooperative Study","volume":"54","author":"Aisen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2021.102196_bb0025","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial","volume":"289","author":"Aisen","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.npep.2021.102196_bb0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.npep.2021.102196_bb0035","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1096\/fj.10-176602","article-title":"Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation","volume":"25","author":"Alhouayek","year":"2011","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.npep.2021.102196_bb0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde\u201d","volume":"8","author":"Alzheimer","year":"1995","journal-title":"Clin. Anat."},{"key":"10.1016\/j.npep.2021.102196_bb0045","article-title":"Alzheimers disease facts and figures","volume":"2021","author":"Alzheimer'\u2019s Association","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.npep.2021.102196_bb0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fncel.2019.00424","article-title":"The endocannabinoid system as a window into micoglial biology and its relationship to autism","volume":"13","author":"Araujo","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fnmol.2017.00191","article-title":"The pathophysiological role of microglia in dynamic surveillance, phagocytosis and structural remodeling of the developing CNS","volume":"10","author":"Arcuri","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lfs.2018.12.059","article-title":"The protective effects of beta-caryophyllene on LPS-induced primary microglia M1\/M2 imbalance: a mechanistic evaluation","volume":"219","author":"Askari","year":"2019","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.npep.2021.102196_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-2012-111862","article-title":"CB1 agonist ACEA protects neurons and reduces the cognitive impairment of A\u03b2PP\/PS1 mice","volume":"30","author":"Aso","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pnpbp.2011.12.001","article-title":"CB2: therapeutic target-in-waiting","volume":"38","author":"Atwood","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.npep.2021.102196_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer\u2019s disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102196_bb0080","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"issue":"35","key":"10.1016\/j.npep.2021.102196_bb0085","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0090","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1523\/JNEUROSCI.3923-04.2005","article-title":"A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis","volume":"25","author":"Benito","year":"2005","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.npep.2021.102196_bb0095","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1476-5381.2012.01889.x","article-title":"\u03b2-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-alpha, PPAR-gamma and TRPV1, but not CB(1) or CB(2) receptors","volume":"166","author":"Benito","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.npep.2021.102196_bb0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ACO.0000000000000616","article-title":"An overview of the cannabinoid type 2 receptor system and its therapeutic potential","volume":"31","author":"Bie","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.npep.2021.102196_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12011","article-title":"Review: activation patterns of microglia and their identification in the human brain","volume":"39","author":"Boche","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.npep.2021.102196_bb0110","first-page":"15","article-title":"Molecular biology of cannabinoid receptors","volume":"69","author":"Bonner","year":"1996","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.npep.2021.102196_bb0115","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1476-5381.2011.01445.x","article-title":"The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice","volume":"165","author":"Booker","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.npep.2021.102196_bb0120","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/syn.20569","article-title":"Postsynaptic localization of CB2 receptors in the rat hippocampus","volume":"62","author":"Brusco","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.npep.2021.102196_bb0125","article-title":"Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story","author":"Carbone","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.npep.2021.102196_bb0130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1124\/mol.65.4.999","article-title":"Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism","volume":"65","author":"Carrier","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.npep.2021.102196_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1476-5381.1992.tb14321.x","article-title":"Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism","volume":"106","author":"Caulfield","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2011.01.024","article-title":"Endocannabinoid 2-arachidonoylglycerol protects neurons against beta-amyloid insults","volume":"178","author":"Chen","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2021.102196_bb0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pneurobio.2017.10.007","article-title":"The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for the other inflammatory diseases","volume":"160","author":"Chiurchiu","year":"2018","journal-title":"Prog.Neurobiol."},{"key":"10.1016\/j.npep.2021.102196_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.100","article-title":"CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson\u2019s disease","volume":"48","author":"Chung","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.npep.2021.102196_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1474-4422(07)70293-4","article-title":"Aspirin in Alzheimer\u2019s disease (AD2000): a randomised open-label trial","volume":"7","author":"Bentham","year":"2008","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.npep.2021.102196_bb0165","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.bjp.0707425","article-title":"The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation","volume":"152","author":"Comelli","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2009","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001475","article-title":"No effect of one-year treatment with indomethacin on Alzheimer\u2019s disease progression: a randomized controlled trial","volume":"3","author":"de Jong","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2021.102196_bb0180","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1523\/JNEUROSCI.23-06-02371.2003","article-title":"Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus","volume":"23","author":"Derkinderen","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0185","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Di Marzo","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.npep.2021.102196_bb0190","doi-asserted-by":"crossref","first-page":"108555","DOI":"10.1016\/j.neuropharm.2021.108555","article-title":"The cannabinoid system and microglia in health and disease","volume":"190","author":"Duffy","year":"2021","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.npep.2021.102196_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1","article-title":"Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB","volume":"422","author":"Egertov\u00e1","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102196_bb0200","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbi.2015.07.021","article-title":"Microglia in Alzheimer\u2019s disease: a multifaceted relationship","volume":"55","author":"ElAli","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid Anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2021.102196_bb0210","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neulet.2006.06.012","article-title":"CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons","volume":"404","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.npep.2021.102196_bb0215","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by supressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0220","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1124\/jpet.107.121566","article-title":"Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence","volume":"322","author":"Esposito","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2021.102196_bb0225","series-title":"Cannabinoids in Neurologic and Mental Disease. Chapter 2","first-page":"15","article-title":"Endocannabinoids and Alzheimer's disease","author":"Fagan","year":"2015"},{"key":"10.1016\/j.npep.2021.102196_bb0230","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0235","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in neurodegenerative disorders and stroke\/brain trauma: from preclinical models to clinical applications","volume":"12","author":"Fernandez-Ruiz","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.npep.2021.102196_bb0240","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1152\/jn.01227.2005","article-title":"Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons","volume":"96","author":"Fisyunov","year":"2006","journal-title":"J. Neurophysiol."},{"issue":"12","key":"10.1016\/j.npep.2021.102196_bb0245","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/glia.23694","article-title":"Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists","volume":"67","author":"Franco","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.npep.2021.102196_bb0250","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","article-title":"Phagocytosis of microglia in the central nervous system diseases","volume":"49","author":"Fu","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0255","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur. J. Biochem."},{"issue":"6A","key":"10.1016\/j.npep.2021.102196_bb0260","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/j.1582-4934.2008.00258.x","article-title":"Activation of cannabinoid receptors prevents antigen induced asthma-like reaction in guinea pigs","volume":"12","author":"Giannini","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.npep.2021.102196_bb0265","first-page":"1362","article-title":"Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors","volume":"56","author":"Glass","year":"1999","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.npep.2021.102196_bb0270","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1476-5381.2011.01414.x","article-title":"Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K\/Akt and the mammalian target of rapamycin (mTOR) pathways","volume":"163","author":"Gomez","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0275","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","article-title":"Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson\u2019s disease","volume":"64","author":"G\u00f3mez-G\u00e1lvez","year":"2016","journal-title":"Proeg. Neuro-Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.npep.2021.102196_bb0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/WAD.0b013e3181611024","article-title":"A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study","volume":"22","author":"G\u00f3mez-Isla","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.npep.2021.102196_bb0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2021.102196_bb0290","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/glia.21094","article-title":"Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFjB signalling, MAPK, and Jak1\/Stat1 pathways","volume":"59","author":"Gorina","year":"2011","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.npep.2021.102196_bb0295","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.tips.2012.03.014","article-title":"GPR119 as a fat sensor","volume":"33","author":"Hansen","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.npep.2021.102196_bb0300","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156720511796391935","article-title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimers disease: two phase 3 studies","volume":"8","author":"Harrington","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.npep.2021.102196_bb0305","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coph.2016.06.009","article-title":"A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1\u03b1 driven immunosuppression and improve immunotherapies of cancer","volume":"29","author":"Hatfield","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0310","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(95)11289-9","article-title":"Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes","volume":"186","author":"Henry","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2021.102196_bb0315","series-title":"The Endocannabinoid Signaling System in the CNS: A Primer. International Review of Neurobiology, Chapter 1","volume":"125","author":"Hillard","year":"2015"},{"key":"10.1016\/j.npep.2021.102196_bb0320","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","article-title":"CB1 and CB2 receptor pharmacology","volume":"80","author":"Howlett","year":"2017","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.npep.2021.102196_bb0325","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1476-5381.2010.01046.x","article-title":"Central and peripheral sites of action for CB\u2082 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats","volume":"162","author":"Hsieh","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.npep.2021.102196_bb0335","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jnc.13267","article-title":"Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB\u2081R signaling and anxiety-like behavior","volume":"135","author":"Imperatore","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2021.102196_bb0340","doi-asserted-by":"crossref","first-page":"4854378","DOI":"10.1155\/2016\/4854378","article-title":"Cannabinoid CB2 receptor mediates nicotine-induced anti-inflammation in N9 microglial cells exposed to \u03b2-amyloid via protein kinase C","volume":"2016","author":"Jia","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.npep.2021.102196_bb0345","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0026-895X(25)09130-8","article-title":"Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation","volume":"42","author":"Kaminski","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0350","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.npep.2021.102196_bb0355","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jnr.20562","article-title":"Microglia in health and disease","volume":"81","author":"Kim","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.npep.2021.102196_bb0365","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.npep.2021.102196_bb0370","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/nature05704","article-title":"UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis","volume":"446","author":"Koizumi","year":"2007","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.npep.2021.102196_bb0375","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/glia.22380","article-title":"Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in Muller glia during inflammation","volume":"60","author":"Krishnan","year":"2012","journal-title":"Glia."},{"issue":"3","key":"10.1016\/j.npep.2021.102196_bb0380","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/jhet.2861","article-title":"Microwave-accelerated conjugate addition of 2-arylindoles to substituted \u03b2-nitrostyrenes in the presence of ammonium trifluoroacetate: an efficient approach for the synthesis of a novel class of CB1 cannabinoid receptor allosteric modulators","volume":"54","author":"Kulkarni","year":"2017","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.npep.2021.102196_bb0385","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0390","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1097-2765(04)00237-0","article-title":"Clearance of apoptotic cells: getting rid of the corpses","volume":"14","author":"Lauber","year":"2004","journal-title":"Mol. Cell"},{"issue":"27","key":"10.1016\/j.npep.2021.102196_bb0395","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1523\/JNEUROSCI.4112-14.2015","article-title":"Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release","volume":"35","author":"Lee","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0400","first-page":"17","article-title":"Microglia in Alzheimer\u2019s disease","volume":"437483","author":"Li","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.npep.2021.102196_bb0405","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.117.241901","article-title":"Cannabinoid CB2 agonist GW405833 suppresses inflammatory and neuropathic pain through a CB1 mechanism that is independent of CB2 receptors in mice","volume":"362","author":"Li","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2021.102196_bb0410","doi-asserted-by":"crossref","first-page":"e000012","DOI":"10.1136\/svn-2016-000012","article-title":"Neurotransmitter receptors on microglia","volume":"1","author":"Liu","year":"2016","journal-title":"Stroke Vasc. Neurol."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0415","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2004.04.039","article-title":"Cannabinoid agonists induce contractile responses through Gi\/o-dependent activation of phospholipase C in the bovine ciliary muscle","volume":"494","author":"Lograno","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.npep.2021.102196_bb0420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1369-1600.2010.00222.x","article-title":"Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors","volume":"15","author":"Luchicchi","year":"2010","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0425","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2009.09.021","article-title":"1-(2\u2032,4\u2032-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice","volume":"37","author":"Luongo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2021.102196_bb0430","doi-asserted-by":"crossref","first-page":"12440","DOI":"10.1038\/srep12440","article-title":"Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions","volume":"5","author":"Ma","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0435","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2015.01.073","article-title":"Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling","volume":"458","author":"Ma","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2021.102196_bb0440","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10571-018-0628-z","article-title":"PGC-1alpha-mediated mitochondrial biogenesis is involved in cannabinoid receptor 2 agonist AM1241-induced microglial phenotype amelioration","volume":"38","author":"Ma","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.npep.2021.102196_bb0445","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/mp.2009.62","article-title":"Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain","volume":"14","author":"Marchalant","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.npep.2021.102196_bb0450","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.npep.2021.102196_bb0455","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzhemier\u2019s disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.npep.2021.102196_bb0460","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0165-5728(86)90033-0","article-title":"In situ detection of class I and II major histocompatibility complex antigens in the rat central nervous system during experimental allergic encephalomyelitis. An immunohistochemical study","volume":"12","author":"Matsumoto","year":"1986","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.npep.2021.102196_bb0465","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.npep.2021.102196_bb0470","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.npep.2021.102196_bb0475","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: therapeutic implications","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.npep.2021.102196_bb0480","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s43088-021-00121-y","article-title":"Role of endocannabinoid CB1 receptors in streptozotocin-induced nephrectomised Wistar rats in diabetic nephropathy","volume":"10","author":"Medapati","year":"2021","journal-title":"Beni-seuf Univ. J. Basic Appl. Sci."},{"issue":"2","key":"10.1016\/j.npep.2021.102196_bb0485","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mcn.2008.10.015","article-title":"A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules","volume":"40","author":"Mestre","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"issue":"Pt 4","key":"10.1016\/j.npep.2021.102196_bb0490","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/brain\/awr046","article-title":"Molecular reorganization of endocannabinoid signalling in Alzheimer\u2019s disease","volume":"134","author":"Mulder","year":"2011","journal-title":"Brain."},{"issue":"6441","key":"10.1016\/j.npep.2021.102196_bb0495","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.npep.2021.102196_bb0500","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0505","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1742-2094-9-79","article-title":"The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation","volume":"9","author":"Murphy","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.npep.2021.102196_bb0510","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.npep.2021.102196_bb0515","first-page":"406","article-title":"Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders","volume":"10","author":"Navvaro","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0525","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1523\/JNEUROSCI.22-10-03864.2002","article-title":"Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses","volume":"22","author":"Ohno-Shosaku","year":"2002","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.npep.2021.102196_bb0530","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbrc.2007.08.078","article-title":"Identification of GPR55 as a lysophosphatidylinositol receptor","volume":"362","author":"Oka","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt 11","key":"10.1016\/j.npep.2021.102196_bb0535","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.npep.2021.102196_bb0540","doi-asserted-by":"crossref","unstructured":"Pamplona, F.A., Ferreira, J., Menezes de Lima O Jr. 2013., Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. Proc Natl Acad Sci U S A. 2012;109(51):21134\u20139. Erratum in: Proc Natl Acad Sci USA. 2013;110(4):1561. Bellochio, Luigi [corrected to Bellocchio, Luigi]. doi:https:\/\/doi.org\/10.1073\/pnas.1202906109.","DOI":"10.1073\/pnas.1221727110"},{"key":"10.1016\/j.npep.2021.102196_bb0545","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fncel.2014.00129","article-title":"Fractalkine regulation of microglial physiology and consequences on the brain and behavior","volume":"8","author":"Paolicelli","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0550","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2019.08.001","article-title":"The acute activation of the CB1 receptor in the hippocampus decreases neurotoxicity and prevents spatial memory impairment in rats lesioned with \u03b2-amyloid 25\u201335","volume":"416","author":"Patricio-Mart\u00ednez","year":"2019","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.npep.2021.102196_bb0555","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2021.102196_bb0560","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"29","author":"Price","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0565","doi-asserted-by":"crossref","first-page":"111703","DOI":"10.1016\/j.biopha.2021.111703","article-title":"New insights in drug development for Alzheimer\u2019s disease based on microglia function","volume":"140","author":"Qiao","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.npep.2021.102196_bb0570","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ramirez","year":"2005","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.npep.2021.102196_bb0575","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4628-11.2012","article-title":"Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions","volume":"32","author":"Ramirez","year":"2012","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.npep.2021.102196_bb0580","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaim.2017.06.013","article-title":"Vitis vinifera acts as anti-Alzheimer's agent by modulating biochemical parameters implicated in cognition and memory","volume":"10","author":"Rapaka","year":"2019","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.npep.2021.102196_bb0585","doi-asserted-by":"crossref","first-page":"102151","DOI":"10.1016\/j.npep.2021.102151","article-title":"Benincasa hispida alleviates amyloid pathology by inhibition of Keap1\/ Nrf2-axis: emphasis on oxidative and inflammatory stress involved in Alzheimer\u2019s disease model","volume":"88","author":"Rapaka","year":"2021","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102196_bb0590","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.immuni.2011.09.004","article-title":"Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways","volume":"35","author":"Ravichandran","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.npep.2021.102196_bb0595","doi-asserted-by":"crossref","unstructured":"Reines, S.A., Block, G.A., Morris, J.C., et al., 2004. Rofecoxib Protocol 091 Study Group. Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology. 62(1):66\u201371. doi:https:\/\/doi.org\/10.1212\/wnl.62.1.66.","DOI":"10.1212\/WNL.62.1.66"},{"key":"10.1016\/j.npep.2021.102196_bb0600","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrneurol.2017.17","article-title":"Microglia-induced reactive astrocytes \u2014 toxic players inneurological disease?","volume":"13","author":"Ridler","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.npep.2021.102196_bb0605","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt146","article-title":"Oral curcumin for Alzheimer\u2019s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study","volume":"4","author":"Ringman","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.npep.2021.102196_bb0610","first-page":"68","article-title":"El tercer elemento de los centros nerviosos I. La microgl\u00eda en estado normal","volume":"9","author":"R\u00edo-Hortega","year":"1919","journal-title":"Bol. Soc. Espanol. Biol."},{"issue":"2","key":"10.1016\/j.npep.2021.102196_bb0615","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11481-015-9611-3","article-title":"A CB2-selective cannabinoid suppresses T-cell activities and increases tregs and IL-10","volume":"10","author":"Robinson","year":"2015","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.npep.2021.102196_bb0620","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1744-8069-5-25","article-title":"Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation","volume":"5","author":"Romero-Sandoval","year":"2009","journal-title":"Mol. Pain"},{"key":"10.1016\/j.npep.2021.102196_bb0625","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nri957","article-title":"A blast from the past: clearance of apoptotic cells regulates immune responses","volume":"2","author":"Savill","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.npep.2021.102196_bb0630","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.npep.2021.102196_bb0635","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/j.1582-4934.2011.01267.x","article-title":"Palmitoylethanolamide counteracts reactive astrogliosis induced by beta-amyloid peptide","volume":"15","author":"Scuderi","year":"2011","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0640","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1471-4159.2006.04346.x","article-title":"The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset","volume":"101","author":"Shoemaker","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2021.102196_bb0645","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-2094-8-92","article-title":"TLR4 mutation reduces microglial activation, increases A\u03b2 deposits and exacerbates cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"8","author":"Song","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0650","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","article-title":"Endocannabinoid signaling in microglial cells","volume":"56","author":"Stella","year":"2009","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.npep.2021.102196_bb0655","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20983","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.npep.2021.102196_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jnr.20093","article-title":"Microglia and Alzheimer\u2019s disease pathogenesis","volume":"77","author":"Streit","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2021.102196_bb0665","doi-asserted-by":"crossref","first-page":"102109","DOI":"10.1016\/j.npep.2020.102109","article-title":"Adrenomedullin 2 attenuates LPS-induced inflammation in microglia cells by receptor-mediated cAMP-PKA pathway","volume":"85","author":"Sun","year":"2021","journal-title":"Neuropeptides"},{"issue":"23","key":"10.1016\/j.npep.2021.102196_bb0670","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1523\/JNEUROSCI.0247-14.2014","article-title":"Presynaptic calcium channel inhibition underlies CB\u2081 cannabinoid receptor-mediated suppression of GABA release","volume":"34","author":"Szab\u00f3","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0675","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1759-1961.2009.00001.x","article-title":"Neurotoxicity by microglia: mechanisms and potential therapeutic strategy","volume":"1","author":"Takeuchi","year":"2010","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"30","key":"10.1016\/j.npep.2021.102196_bb0680","doi-asserted-by":"crossref","first-page":"21362","DOI":"10.1074\/jbc.M600504200","article-title":"Tumor necrosis factor-\u03b1 induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner","volume":"281","author":"Takeuchi","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0685","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12974-016-0783-4","article-title":"WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6 independent mechanism","volume":"14","author":"Tanaka","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.npep.2021.102196_bb0690","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fneur.2020.00087","article-title":"Endocannabinoid modulation of microglial phenotypes in neuropathology","volume":"11","author":"Tanaka","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.npep.2021.102196_bb0695","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1038\/srep10682","article-title":"Primary macrophage chemotaxis induced by cannabinoid receptor 2 agonists occurs independently of the CB2 receptor","volume":"5","author":"Taylor","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.npep.2021.102196_bb0700","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clinbiochem.2019.04.001","article-title":"Neuro-inflammation and anti-inflammatory treatment options for Alzheimer\u2019s Disease","volume":"72","author":"Tomris","year":"2019","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.npep.2021.102196_bb0705","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/jn.1997.78.1.43","article-title":"Cannabinoids inhibit N- and P\/Q-type calcium channels in cultured rat hippocampal neurons","volume":"78","author":"Twitchell","year":"1997","journal-title":"J. Neurophysiol."},{"issue":"10","key":"10.1016\/j.npep.2021.102196_bb0710","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.387","article-title":"The inhibition of 2-arachidonoylglycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG","volume":"4","author":"Valdeolivas","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.npep.2021.102196_bb0715","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(01)05623-9","article-title":"Effect of hydroxychloroquine on progression of dementia in early Alzheimer\u2019s disease: an 18- month randomised, double-blind, placebo-controlled study","volume":"358","author":"Van Gool","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.npep.2021.102196_bb0720","article-title":"How do stupendous cannabinoids modulate memory processing via affecting neurotransmitter systems?","author":"Vaseghi","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.npep.2021.102196_bb0725","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u00df deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"issue":"14","key":"10.1016\/j.npep.2021.102196_bb0730","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1523\/JNEUROSCI.0786-09.2009","article-title":"Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K\/Akt pathway","volume":"29","author":"Viscomi","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.npep.2021.102196_bb0735","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0022-3565(24)38093-0","article-title":"The central cannabinoid receptor(CB1) mediates inhibition of nitric oxide production by rat microglial cells","volume":"288","author":"Waksman","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.npep.2021.102196_bb0740","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102196_bb0745","doi-asserted-by":"crossref","first-page":"101998","DOI":"10.1016\/j.npep.2019.101998","article-title":"Signaling molecules targeting cannabinoid receptors: hemopressin and related peptides","volume":"79","author":"Wei","year":"2020","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/j.npep.2021.102196_bb0750","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nri1843","article-title":"Immunology and immunotherapy of Alzheimer\u2019s disease","volume":"6","author":"Weiner","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.npep.2021.102196_bb0755","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/glia.22988","article-title":"Targeting microglia for the treatment of Alzheimer\u2019s Disease","volume":"64","author":"Wes","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.npep.2021.102196_bb0760","doi-asserted-by":"crossref","unstructured":"Wilcock, GK., Black, SE., Hendrix, SB., Zavitz, KH., Swabb, EA., Laughlin, MA., 2008. Tarenflurbil Phase II Study investigators. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. Lancet Neurol. 7(6):483\u201393. Erratum in: Lancet Neurol. 2008: 7(7):575. Erratum in: Lancet Neurol. 2011;10(4):297. doi:https:\/\/doi.org\/10.1016\/s1474-4422(08)70090-5.","DOI":"10.1016\/S1474-4422(08)70090-5"},{"issue":"3","key":"10.1016\/j.npep.2021.102196_bb0765","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-5728(91)90110-S","article-title":"Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production","volume":"33","author":"Woodroofe","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.npep.2021.102196_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1381612824666180327165604","article-title":"Signaling pathways in inflammation and anti-inflammatory therapies","volume":"24","author":"Yeung","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.npep.2021.102196_bb0775","doi-asserted-by":"crossref","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2021.102196_bb0780","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/npp.2014.297","article-title":"Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats","volume":"40","author":"Zhang","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.npep.2021.102196_bb0785","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.npep.2021.102196_bb0790","doi-asserted-by":"crossref","first-page":"e81618","DOI":"10.1371\/journal.pone.0081618","article-title":"Monoacylglycerols activate TRPV1- a link between phospholipase C and TRPV1","volume":"8","author":"Zygmunt","year":"2013","journal-title":"PLoS One"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:38:41Z","timestamp":1758919121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417921000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":156,"alternative-id":["S0143417921000822"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2021.102196","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2021.102196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102196"}}